Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: the role of streptogramins and other newer compounds-Reference-Cited by-同舟云学术

Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: the role of streptogramins and other newer compounds

Published:1999-02 Issue:2 Volume:33 Page:101-112
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Jones RonaldN,Low DonaldE,Pfaller MichaelA

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference65 articles.

1. Staphylococcus aureus with reduced susceptibility to vancomycin—United States, 1997;Anonymous;JAMA,1997

2. Staphylococcus aureus:;Archer;Clin Infect Dis,1998

3. Mechanisms of glycopeptide resistance in enterococci;Arthur;J Infect Dis,1996

4. Provisional interpretive criteria for quinupristin/dalfopristin susceptibility tests;Barry;J Antimicrob Chemother,1997

5. In vitro conjugative transfer of Van A vancomycin resistance between enterococci and Listeriae of different species;Biavasco;Eur J Clin Microbiol Infect Dis,1996

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Achilles tendon complications of fluoroquinolone treatment: a molecule-stratified systematic review and meta-analysis;EFORT Open Reviews;2024-07-01

2. A Review of the Resistance Mechanisms for β-Lactams, Macrolides and Fluoroquinolones among Streptococcus pneumoniae;Medicina;2023-10-31

3. Design, Synthesis, in Silico Study and Biological Evaluation of 1,8-Naphthyridine Derivatives as Potential Antibacterial Agents;Oriental Journal Of Chemistry;2023-04-30

4. Novel fluoroquinolone hybrids as dual DNA gyrase and urease inhibitors with potential antibacterial activity: Design, synthesis, and biological evaluation;Journal of Molecular Structure;2023-01

5. Stevens-Johnson Syndrome Following Vancomycin and Linezolid: A Real-World Analysis of Post-Marketing Surveillance Data;Frontiers in Pharmacology;2022-04-28